HairDx Finds German Distributor | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular dermatology company PharmaGenoma said today that it has signed up Svenson Haar Studios to distribute its HairDx subsidiary’s genetic test to predict the likelihood of a common type of hair loss.

Svenson will distribute the HairDx test, which provides a gene-based analysis of the chances that men and women will develop androgenetic alopecia, through a network of 17 centers throughout Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.